Prospective Analysis on Survival Outcomes of Nonsmall Cell Lung Cancer Stages over Ⅲb Treated with HangAm-Dan

BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) stages over Ⅲb still remain as an intractable disease. Survival rate of NSCLC stages over Ⅲb could be increased through chemotherapy and radiation, but results are not satisfactory. Oriental medicine herbal formula, HangAm-Dan (HAD) has be...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Zhongguo Fei Ai Za Zhi
Egile Nagusiak: JEONG, Tae-Young, PARK, Bong-Ky, LEE, Yeon-Weol, CHO, Chong-Kwan, YOO, Hwa-Seung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 中国肺癌杂志编辑部 2010
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000501/
https://ncbi.nlm.nih.gov/pubmed/21081039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.03
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak